Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial-Reference-Cited by-同舟云学术

Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial

Published:2003-03 Issue:3 Volume:14 Page:414-420
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Mustacchi G.,Ceccherini R.,Milani S.,Pluchinotta A.,De Matteis A.,Maiorino L.,Farris A.,Scanni A.,Sasso F.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/14/3/414/557477/mdg117.pdf

Reference40 articles.

1. The frequency and age distribution of mammary carcinoma;Haagensen,1971

2. Tamoxifen (antioestrogen) therapy in advanced breast cancer;Kiang;Ann Intern Med,1977

3. The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot study;Campbell;Clin Oncol,1984

4. Treatment of primary breast cancer with chemotherapy and tamoxifen;Fisher B;N Engl J Med,1981

5. Tamoxifen for early breast cancer: an overview of the randomized trials;Lancet,1998

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management and outcomes for older women with early breast cancer treated with primary endocrine therapy (PET);The Breast;2024-10

2. Avoiding Locoregional Overtreatment in Older Adults With Early-Stage Breast Cancer;Clinical Breast Cancer;2024-06

3. Neo-adjuvant therapies for ER positive/HER2 negative breast cancers: from chemotherapy to hormonal therapy, CDK inhibitors, and beyond;Expert Review of Anticancer Therapy;2024-03-18

4. A novel bystander effect in tamoxifen treatment: PPIB derived from ER+ cells attenuates ER− cells via endoplasmic reticulum stress-induced apoptosis;Cell Death & Disease;2024-02-15

5. Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer;Cancer Treatment Reviews;2024-02